Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-01-25

Clinical Trial Update: Micro-Particle Curcumin for the Treatment of Chronic Kidney Disease [Phase 3]

View source ↗

Summary

Phase 3 trial update on micro-particle curcumin for chronic kidney disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • micro-particle curcumin

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Chronic Kidney Disease | Phase 3 | Status: COMPLETED